The major finding is that cathelicidin may protect against hyperoxia-induced kidney injury through the inhibition of the oxidative stress and NF-κB activity, thereby suggesting that cathelicidin may be a promising treatment modality against hyperoxia-induced kidney injury. The gene discussed is NFKB1; the disease is kidney injury.